博世科(300422.SZ):聯合體簽訂淮上區百川高端生物產業園污水處理項目EPC總承包項目合同
格隆匯 12 月 16日丨博世科(300422.SZ)公佈,公司於2020年10月14日在中國證監會指定的信息披露網站巨潮資訊網(http://www.cninfo.com.cn)刊登了《關於聯合體中標EPC項目的公告》,公司作為牽頭方,與華設設計集團股份有限公司(“華設集團”,曾用名“中設設計集團股份有限公司”)組成的聯合體成為“淮上區百川高端生物產業園污水處理項目EPC總承包項目”的中標單位,項目概算為1.69億元。
近日,聯合體與發包人安徽百川生物醫藥產業園有限公司(“百川生物”)根據相關法律法規的規定,在平等、自願的基礎上籤訂《淮上區百川高端生物產業園污水處理項目EPC總承包項目合同》(“主合同”),公司負責項目採購、安裝、調試、運行、施工工作,華設集團負責設計工作。
此次聯合體與百川生物簽訂《淮上區百川高端生物產業園污水處理項目EPC總承包項目合同》,合同金額暫定為人民幣1.69億元,有利於公司進一步開拓和鞏固生物及製藥行業污水處理市場,同時也是公司深入拓展安徽業務市場的重要成果。若項目能順利實施,將對公司未來經營業績產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.